Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
- Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
- Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
- Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
- Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT

URLs:
Website: https://go.evvnt.com/3312323-0?pid=2874
Virtual: https://go.evvnt.com/3312323-3?pid=2874

Date and Time: Wednesday, 22 October 2025 at 07:30 - Thursday, 23 October 2025 at 16:45

Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education)

Prices:
Standard Registration-Physicians MD/DO : USD 1495.00,
Nurses/Advanced Practice Professionals/Retired/Active Military : USD 1395.00,
Radiologic Technologists/Residents/Fellows : USD 1295.00

Speakers: Phillip Kuo, MD, PhD, FACR, Don C. Yoo, MD